Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PulteGroup | PHM | Aug 30, 2024 | 131.65 | +1.17 |
Puma Biotechnology | PBYI | Aug 30, 2024 | 2.50 | +2.04 |
Pure Cycle | PCYO | Aug 30, 2024 | 10.65 | +0.95 |
Pure Storage A | PSTG | Aug 30, 2024 | 51.29 | +1.93 |
PureCycle Technologies | PCT | Aug 30, 2024 | 6.10 | +2.35 |
PureCycle Technologies Unit | PCTTU | Aug 30, 2024 | 6.91 | -0.43 |
Purefunds ISE Junior Silver [Sm | SILJ | Aug 30, 2024 | 11.98 | -0.50 |
PureTech Health ADR | PRTC | Aug 30, 2024 | 23.00 | +1.46 |
Purple Biotech ADR | PPBT | Aug 30, 2024 | 0.49 | +6.30 |
Purple Innovation | PRPL | Aug 30, 2024 | 1.20 | -3.23 |
Putnam Managed Municipal Income Trust | PMM | Aug 30, 2024 | 6.33 | -0.63 |
Putnam Master Intermediate Income Trust | PIM | Aug 30, 2024 | 3.35 | +0.30 |
Putnam Municipal Opportunities Trust | PMO | Aug 30, 2024 | 10.43 | -0.19 |
Putnam Premier Income Trust | PPT | Aug 30, 2024 | 3.69 | +0.27 |
PVH | PVH | Aug 30, 2024 | 98.69 | +1.86 |
Pyrophyte Acquisition | PHYT | Aug 30, 2024 | 11.50 | 0.00 |
Pyxis Oncology | PYXS | Aug 30, 2024 | 3.79 | +3.55 |
Pyxis Tankers | PXS | Aug 30, 2024 | 5.11 | +1.39 |
Pyxis Tankers Pref | PXSAP | Aug 30, 2024 | 24.80 | +0.41 |
Q2 | QTWO | Aug 30, 2024 | 74.21 | +0.57 |
Q32 Bio | QTTB | Aug 30, 2024 | 43.48 | +10.81 |
QCR | QCRH | Aug 30, 2024 | 77.13 | +0.30 |
QIAGEN | QGEN | Aug 30, 2024 | 45.71 | +0.07 |
Qifu Technology ADR | QFIN | Aug 30, 2024 | 26.49 | +2.28 |
Qilian International | QLI | Aug 30, 2024 | 5.41 | 0.00 |
Qilian International | BGM | Aug 30, 2024 | 6.97 | 0.00 |
QMMM | QMMM | Aug 30, 2024 | 6.29 | 0.00 |
Qomolangma Acquisition | QOMO | Aug 30, 2024 | 11.89 | 0.00 |
Qorvo | QRVO | Aug 30, 2024 | 115.89 | +1.77 |
QT Imaging | QTI | Aug 30, 2024 | 0.69 | +1.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.